ZoBio Sells to Oncodesign Services
BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small molecule drug discovery services. The full press release is below. Dijon, France & Leiden, The Netherlands, January 23rd, 2024 – Oncodesign Services (ODS), a leading Contract Research Organization specialized in drug discovery and […]